Antigen-Presenting Cell Activation and Endogenous Immune Stimulation

The term "Antigen-presenting cell activation and endogenous immune stimulation" does not specify a singular molecular target or receptor, but refers to the activation of immune cells—primarily dendritic cells, macrophages, and B cells (collectively known as antigen-presenting cells, or APCs)—which process and present foreign or endogenous antigens to T cells, thereby initiating and regulating adaptive immune responses. This multistep process involves numerous molecules and pathways, including MHC class I and II, costimulatory molecules such as CD80 and CD86 (B7 family), pattern recognition receptors like Toll-like receptors, and intracellular signaling cascades. The therapeutic modulation of this process underpins the mechanisms of many immunotherapies, especially in cancer and infectious disease, but is not attributed to a distinct molecular “target”. In summary: This entry does not represent a specific canonical therapeutic target (like a single receptor or enzyme) but rather a biological process involving multiple cell types and pathways. For structured drug development or target databases, you should map constituent molecules involved in APC activation (e.g., CD80, CD86, MHC class II, TLRs, CTLA-4) to their respective, specific entries.

Other names

Antigen-presenting cell activationEndogenous immune stimulationAPC activationImmune activation by antigen presentation